发明名称 ПРОИЗВОДНЫЕ ТИАЗОЛА
摘要 (Wherein n is an integer of from 0 to 3; R 1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R 2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, -COR 8 , or the like; R 3 and R 4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, -COR 12 , or the like) For example, provided are adenosine A 2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.
申请公布号 EA200601235(A1) 申请公布日期 2006.12.29
申请号 EA20060001235 申请日期 2004.12.24
申请人 КИОВА ХАККО КОГИО КО., ЛТД. 发明人 Накадзима Такао;Сугавара Масамори;Утида Син-ити;Охно Тецудзи;Номото Юдзи;Уесака Нориаки;Накасато Йосисуке
分类号 C07D417/04;A61K31/427;A61K31/438;A61K31/4439;A61K31/444;A61K31/454;A61K31/4725;A61K31/496;A61K31/497;A61K31/4985;A61K31/501;A61K31/506;A61K31/5383;A61K31/541;A61K31/542;A61K31/551;A61K31/553;A61K31/695;A61P3/10;A61P9/10;A61P25/00;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;C07D417/14;C07D487/04;C07D491/113;C07D498/04;C07D513/04 主分类号 C07D417/04
代理机构 代理人
主权项
地址